BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8619564)

  • 1. Preliminary in Vitro Studies on
    Nicolosi D; Genovese C; Cutuli MA; D'Angeli F; Pietrangelo L; Davinelli S; Petronio Petronio G; Di Marco R
    Microorganisms; 2020 Mar; 8(4):. PubMed ID: 32218312
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-infective properties of proton pump inhibitors: perspectives.
    da Rosa TF; Foletto VS; Serafin MB; Bottega A; Hörner R
    Int Microbiol; 2022 Jan; 25(1):217-222. PubMed ID: 34476634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complicated urinary tract infection is associated with uroepithelial expression of proinflammatory protein S100A8.
    Reyes L; Alvarez S; Allam A; Reinhard M; Brown MB
    Infect Immun; 2009 Oct; 77(10):4265-74. PubMed ID: 19667050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biology and pathogenicity of mycoplasmas.
    Razin S; Yogev D; Naot Y
    Microbiol Mol Biol Rev; 1998 Dec; 62(4):1094-156. PubMed ID: 9841667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori infection, chronic gastritis, and proton pump inhibitors.
    Dattilo M; Figura N
    J Clin Gastroenterol; 1998; 27 Suppl 1():S163-9. PubMed ID: 9872516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.
    Welage LS; Berardi RR
    J Am Pharm Assoc (Wash); 2000; 40(1):52-62; quiz 121-3. PubMed ID: 10665250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibition of Ureaplasma urealyticum by the proton pump inhibitor lansoprazole: direct attribution to inhibition by lansoprazole of urease activity and urea-induced ATP synthesis in U. urealyticum.
    Nagata K; Takagi E; Satoh H; Okamura H; Tamura T
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2187-92. PubMed ID: 8619564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory action of lansoprazole and its analogs against Helicobacter pylori: inhibition of growth is not related to inhibition of urease.
    Nagata K; Takagi E; Tsuda M; Nakazawa T; Satoh H; Nakao M; Okamura H; Tamura T
    Antimicrob Agents Chemother; 1995 Feb; 39(2):567-70. PubMed ID: 7726537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells.
    Nagata K; Satoh H; Iwahi T; Shimoyama T; Tamura T
    Antimicrob Agents Chemother; 1993 Apr; 37(4):769-74. PubMed ID: 8494373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori urease inhibition by rabeprazole, a proton pump inhibitor.
    Tsuchiya M; Imamura L; Park JB; Kobashi K
    Biol Pharm Bull; 1995 Aug; 18(8):1053-6. PubMed ID: 8535394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth inhibitory and bactericidal activities of lansoprazole compared with those of omeprazole and pantoprazole against Helicobacter pylori.
    Nakao M; Malfertheiner P
    Helicobacter; 1998 Mar; 3(1):21-7. PubMed ID: 9546114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxygen concentration influences proton pump inhibitor activity against Helicobacter pylori in vitro.
    Midolo PD; Turnidge JD; Lambert JR; Bell JM
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1531-3. PubMed ID: 8726032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EFFECT OF PH ON HUMAN MYCOPLASMA STRAINS.
    SHEPARD MC; LUNCEFORD CD
    J Bacteriol; 1965 Feb; 89(2):265-70. PubMed ID: 14255688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrolysis of urea by Ureaplasma urealyticum generates a transmembrane potential with resultant ATP synthesis.
    Smith DG; Russell WC; Ingledew WJ; Thirkell D
    J Bacteriol; 1993 Jun; 175(11):3253-8. PubMed ID: 8501029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteus mirabilis urease: histidine 320 of UreC is essential for urea hydrolysis and nickel ion binding within the native enzyme.
    Sriwanthana B; Mobley HL
    Infect Immun; 1993 Jun; 61(6):2570-7. PubMed ID: 8500894
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.